{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:38:03Z","timestamp":1791326283322,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.trsl.2023.01.004","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T11:13:50Z","timestamp":1674731630000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG)"],"prefix":"10.1016","volume":"257","author":[{"given":"Bijina","family":"Balakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqaiah","family":"Altassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Budhraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willisa","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya","family":"Mankouski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Radenkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihem","family":"Boudina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Kozicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trsl.2023.01.004_bib0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10545-014-9757-9","article-title":"Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function","volume":"38","author":"Beamer","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.trsl.2023.01.004_bib0002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","article-title":"Muscle glycogenosis due to phosphoglucomutase 1 deficiency","volume":"361","author":"Stojkovic","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.trsl.2023.01.004_bib0003","first-page":"137","article-title":"Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient","volume":"35","author":"Ondruskova","year":"2014","journal-title":"Neuro Endocrinol Lett"},{"issue":"4","key":"10.1016\/j.trsl.2023.01.004_bib0004","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nmd.2017.01.014","article-title":"PGM1 deficiency: substrate use during exercise and effect of treatment with galactose","volume":"27","author":"Voermans","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.trsl.2023.01.004_bib0005","first-page":"87","article-title":"A case with rare type of congenital disorder of glycosylation: Pgm1-Cdg","volume":"26","author":"Kucukcongar","year":"2015","journal-title":"Genet Couns"},{"issue":"3","key":"10.1016\/j.trsl.2023.01.004_bib0006","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10545-012-9525-7","article-title":"A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene","volume":"36","author":"Perez","year":"2013","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.trsl.2023.01.004_bib0007","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","article-title":"Multiple phenotypes in phosphoglucomutase 1 deficiency","volume":"370","author":"Tegtmeyer","year":"2014","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.trsl.2023.01.004_bib0008","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1093\/hmg\/dds123","article-title":"Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing","volume":"21","author":"Timal","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.trsl.2023.01.004_bib0009","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jimd.12286","article-title":"International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): diagnosis, follow-up, and management","volume":"44","author":"Altassan","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.trsl.2023.01.004_bib0010","first-page":"29","article-title":"Galactose treatment of a PGM1 patient presenting with restrictive cardiomyopathy","volume":"57","author":"Donoghue","year":"2021","journal-title":"JIMD Rep"},{"issue":"4","key":"10.1016\/j.trsl.2023.01.004_bib0011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2014.06.002","article-title":"Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG","volume":"112","author":"Morava","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"11","key":"10.1016\/j.trsl.2023.01.004_bib0012","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2017.41","article-title":"Oral D-galactose supplementation in PGM1-CDG","volume":"19","author":"Wong","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.trsl.2023.01.004_bib0013","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ajhg.2019.03.003","article-title":"The metabolic map into the pathomechanism and treatment of PGM1-CDG","volume":"104","author":"Radenkovic","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"1-2","key":"10.1016\/j.trsl.2023.01.004_bib0014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymgme.2020.08.003","article-title":"Phosphoglucomutase-1 deficiency: early presentation, metabolic management and detection in neonatal blood spots","volume":"131","author":"Conte","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"7","key":"10.1016\/j.trsl.2023.01.004_bib0015","first-page":"923","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.trsl.2023.01.004_bib0016","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jimd.12110","article-title":"A novel phosphoglucomutase-deficient mouse model reveals aberrant glycosylation and early embryonic lethality","volume":"42","author":"Balakrishnan","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.trsl.2023.01.004_bib0017","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10545-010-9081-y","article-title":"Biochemical diagnosis of mitochondrial disorders","volume":"34","author":"Rodenburg","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.trsl.2023.01.004_bib0018","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41398-020-0858-y","article-title":"Impaired mitochondrial complex I function as a candidate driver in the biological stress response and a concomitant stress-induced brain metabolic reprogramming in male mice","volume":"10","author":"Emmerzaal","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.trsl.2023.01.004_bib0019","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jimd.12557","article-title":"N-glycoproteomics reveals distinct glycosylation alterations in NGLY1-deficient patient-derived dermal fibroblasts","volume":"46","author":"Budhraja","year":"2022","journal-title":"J Inherit Metab Dis"},{"issue":"21","key":"10.1016\/j.trsl.2023.01.004_bib0020","doi-asserted-by":"crossref","first-page":"14466","DOI":"10.1021\/acs.analchem.0c02513","article-title":"PASS-DIA: a data-independent acquisition approach for discovery studies","volume":"92","author":"Mun","year":"2020","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.trsl.2023.01.004_bib0021","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1021\/acs.jproteome.1c00391","article-title":"Mass spectrometric analysis of urine from COVID-19 patients for detection of SARS-CoV-2 viral antigen and to study host response","volume":"20","author":"Chavan","year":"2021","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.trsl.2023.01.004_bib0022","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ajhg.2019.03.003","article-title":"The metabolic map into the pathomechanism and treatment of PGM1-CDG","volume":"104","author":"Radenkovic","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.trsl.2023.01.004_bib0023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/hh1301.092687","article-title":"Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein","volume":"89","author":"Sohal","year":"2001","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.trsl.2023.01.004_bib0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCRESAHA.109.198416","article-title":"Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models","volume":"105","author":"Koitabashi","year":"2009","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.trsl.2023.01.004_bib0025","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/CIRCRESAHA.118.314238","article-title":"DNA damage response\/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (lamin A\/C) mutations","volume":"124","author":"Chen","year":"2019","journal-title":"Circ Res"},{"issue":"17","key":"10.1016\/j.trsl.2023.01.004_bib0026","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.3390\/ijms21176013","article-title":"Change the laminin, change the cardiomyocyte: improve untreatable heart failure","volume":"21","author":"Hochman-Mendez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2023.01.004_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.707087","article-title":"Laminin polymerization and inherited disease: lessons from genetics","volume":"12","author":"Shaw","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.trsl.2023.01.004_bib0028","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fnmol.2020.00123","article-title":"LAMA2-related dystrophies: clinical phenotypes, disease biomarkers, and clinical trial readiness","volume":"13","author":"Sarkozy","year":"2020","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1016\/j.trsl.2023.01.004_bib0029","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/01.WNL.0000138498.66940.7F","article-title":"LAMA2 loss-of-function mutation in a girl with a mild congenital muscular dystrophy","volume":"63","author":"Prandini","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.trsl.2023.01.004_bib0030","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","article-title":"AAV gene therapy prevents and reverses heart failure in a murine knockout model of barth syndrome","volume":"126","author":"Wang","year":"2020","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.trsl.2023.01.004_bib0031","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.trsl.2023.01.004_bib0032","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12265-019-09932-y","article-title":"XPO1 gene therapy attenuates cardiac dysfunction in rats with chronic induced myocardial infarction","volume":"13","author":"Garcia-Manzanares","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"issue":"9","key":"10.1016\/j.trsl.2023.01.004_bib0033","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/CIRCRESAHA.121.320680","article-title":"Gene therapy with the N-terminus of Junctophilin-2 improves heart failure in mice","volume":"130","author":"Wang","year":"2022","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.trsl.2023.01.004_bib0034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cvr\/cvp119","article-title":"Impaired binding of ZASP\/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy","volume":"83","author":"Arimura","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2023.01.004_bib0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/TACG.S187481","article-title":"Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-alpha2 chain-deficient congenital muscular dystrophy","volume":"12","author":"Nguyen","year":"2019","journal-title":"Appl Clin Genet"},{"issue":"5","key":"10.1016\/j.trsl.2023.01.004_bib0036","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.22132","article-title":"Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations","volume":"44","author":"Gavassini","year":"2011","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.trsl.2023.01.004_bib0037","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.nmd.2014.01.004","article-title":"Atypical phenotype in two patients with LAMA2 mutations","volume":"24","author":"Marques","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.trsl.2023.01.004_bib0038","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.nmd.2020.03.009","article-title":"Clinical and genomic characteristics of LAMA2 related congenital muscular dystrophy in a patients' cohort from Qatar. a population specific founder variant","volume":"30","author":"Abdel Aleem","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.trsl.2023.01.004_bib0039","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JND-150093","article-title":"Laminin alpha2 deficiency-related muscular dystrophy mimicking emery-dreifuss and collagen VI related diseases","volume":"2","author":"Nelson","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.trsl.2023.01.004_bib0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mus.10258","article-title":"Inhibition of dystroglycan binding to laminin disrupts the PI3K\/AKT pathway and survival signaling in muscle cells","volume":"26","author":"Langenbach","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.trsl.2023.01.004_bib0041","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.omtm.2021.02.004","article-title":"Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A","volume":"21","author":"Packer","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6853","key":"10.1016\/j.trsl.2023.01.004_bib0042","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35095054","article-title":"An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy","volume":"413","author":"Moll","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.trsl.2023.01.004_bib0043","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jimd.12406","article-title":"A new D-galactose treatment monitoring index for PGM1-CDG","volume":"44","author":"Perales-Clemente","year":"2021","journal-title":"J Inherit Metab Dis"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152442300004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152442300004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:47:06Z","timestamp":1761828426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152442300004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":43,"alternative-id":["S193152442300004X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.01.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG)","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}